Advertising disclosure — We may earn a commission if you start care through some of these links, at no extra cost to you. How we're funded. Order reflects our editorial rubric and our commercial relationships; scores are ours alone.
Head-to-head for women
Goldspan Health vs yourEra
Goldspan Health and yourEra both offer GLP-1 telehealth to women, but they make different trade-offs on PCOS and hormonal suitability, clinical oversight, price and access. Here they are side-by-side on the Luna Fit Score — our women's-health rubric.
Goldspan Health
Ranked #48 for women · Grade B−
Luna Fit
Best for: Women in the menopause transition who want one catalog to carry estradiol, progesterone and a GLP-1, and who do not mind that the checkout sits on another company's domain.
Visit Goldspan HealthyourEra
Higher scoreRanked #4 for women · Grade B
Luna Fit
Best for: Women who want transparently priced semaglutide and tirzepatide plus an optional NAD+, microdosing, and coaching-and-labs menu on one account.
Visit yourEraThe verdict for women
yourEra edges out Goldspan Health on the Luna Fit Score, 86 to 80 (B vs B−). Women who want transparently priced semaglutide and tirzepatide plus an optional NAD+, microdosing, and coaching-and-labs menu on one account. The reasoning behind that number is in our full yourEra review.
Goldspan Health is still a genuine option — the only provider here whose named clinical advisors include an OB-GYN and menopause specialist alongside a medical director credentialed in bioidentical hormone therapy — with estradiol and progesterone priced in the same catalog as the GLP-1s. Weigh the six women's-health factors below against your own priorities; what we found reviewing Goldspan Health goes through each of them, and if neither of these two is the one, the full field we rank against Goldspan Health widens the field.
Side-by-side on the six factors
Both providers scored on the same women's-health rubric — the higher side on each factor is marked. See the methodology.
Price, access & features
| Detail | Goldspan Health | yourEra |
|---|---|---|
| Luna Fit Score | 80/100 · B− | 86/100 · B |
| Overall rank | #48 | #4 |
| Semaglutide | $229 per 28 days month-to-month, injection (13 charges a year); $149 for the sublingual microdose, on the storefront it sells through | $199/mo |
| Tirzepatide | $299 per 28 days month-to-month, injection; $199 for the sublingual microdose | $299/mo |
| Coverage | 50 states and DC per its storefront; its own terms say some therapies are unavailable in certain states | All 50 states |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Yes | Injection only |
Luna Fit
Goldspan Health
Ranked #48 · Grade B−
What we like
- Names three clinical advisors with credentials, including an OB-GYN and menopause specialist and a medical director carrying obesity-medicine and bioidentical hormone certifications
- Prices estradiol cream, progesterone and a women's testosterone option in the same catalog as the GLP-1s, so hormone care is not a second purchase somewhere else
- Requires a lab panel sixty to ninety days after starting and annually after that, drawn through Quest — a written monitoring commitment most of this ranking never makes
The caveats
- Goldspan's own site publishes no price on any page — every figure lives on a storefront run by a different company
- Billing is every 28 days while the headline reads per month: thirteen charges a year, not twelve
- No legal entity, address or governing law is published for Goldspan anywhere; the only company named on the paperwork is the storefront operator
Luna Fit
yourEra
Ranked #4 · Grade B
What we like
- Publicly listed pricing on both molecules — semaglutide from $199/mo and tirzepatide from $299/mo — while many compounders hide price behind a quiz
- Fuller menu beyond GLP-1: NAD+ and microdosing protocols, plus an optional membership adding 1:1 coaching, a nutritionist, and an at-home lab draw
- Markets a 50-state licensed-clinician network, no insurance required, with HSA/FSA accepted
The caveats
- Compounded semaglutide and tirzepatide are not FDA-approved the way brand Wegovy, Ozempic, or Zepbound are, and compounding access can tighten as brand shortages resolve
- Mid-market pricing that sits above the cheapest compounders (roughly $99–$150)
- Injectable only — no oral route and no brand-name lane
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. Pricing, states and verification reflect each provider's public disclosures at last review; the Luna Fit Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.
More head-to-heads
Neither Goldspan Health nor yourEra is only worth comparing with the other. Goldspan Health is also written up against CoreAge Rx, 13 points apart on the Luna Fit Score — see Goldspan Health vs CoreAge Rx for women. yourEra is also written up against CoreAge Rx, 7 points apart — see how yourEra and CoreAge Rx compare on the Luna Fit Score.
- Goldspan Health vs CoreAge Rx
- Goldspan Health vs Enhance MD
- Goldspan Health vs Eden
- yourEra vs Sesame Care
- yourEra vs HealthRX
- yourEra vs MadeMed
Or browse the full comparison hub.